|
Adalimumab targets PsO inflammation, not necessarily heart disease
|
|
Adalimumab may be effective for plaque psoriasis, but not heart disease and other inflammatory conditions associated with the condition. This study confirms that the inflammatory process is unique and that one treatment may not apply to other inflammatory conditions.
|
|
|
|
Heart disease risk high in atopic eczema
|
|
Adults with severe and predominately active atopic eczema are at higher risk for cardiovascular disease outcomes, including myocardial infarction, stroke and death, compared to adults without eczema, shows an observational population-based study published May 23 in the journal BMJ. |
